Literature DB >> 33413206

How do private practitioners in Pakistan manage children suspected having tuberculosis? A cross sectional study.

Aashifa Yaqoob1,2, Sven Gudmund Hinderaker3, Razia Fatima4, Hina Najmi5.   

Abstract

BACKGROUND: In Pakistan, private providers provide a large portion of health care, including for tuberculosis (TB). All TB patients are supposed to be reported to the National Tuberculosis Program (NTP), which provides drugs free of charge in addition to monitoring, supervision, and support. However, diagnosis of TB in children is difficult. We aimed to assess the private health care providers' investigation practices and management of childhood TB.
METHODS: We used a cross-sectional study, which was based on a national survey measuring under-reporting of children with TB in 12 selected districts in Pakistan from April-June, 2016. We explored the practices of the private health care providers, including the health care workers i.e. general practitioners, pediatricians, pulmonologists and chest specialists, who were involved in the diagnosis of TB in children under 15 years for investigating and managing children suspected having TB.
RESULTS: Among 6519 presumptive child TB cases, a total of 5193(79.7%) children under 15 years were diagnosed as TB by private health care providers during second quarter, 2016. Only 187(2.9%) were notified to NTP. The majority of presumptive child TB cases reported cough, fever, and failure to thrive; few had TB contacts with pulmonary TB patients. Failure to thrive, loss of body weight and absence of BCG (Bacillus Calmette-Guérin) scar was more common in female children. Private providers relied on chest X-ray in 46.1%, while tuberculin skin test and Gene-Xpert MTB/RIF testing was little utilized. Bacteriological confirmation was present in 7.6%, and clinical assessment was the only basis for diagnosis in 39.3%. Of children with presumptive TB, only 955(14.6%) children were treated by private provider, while 3121(47.9%) cases were referred for diagnosis and 2443(37.5%) were referred after diagnosis for treatment; among all the referred, 3812(68.5%) were sent for investigations to District TB Centre (NTP).
CONCLUSION: This study showed that many private providers referred children suspected having TB to laboratories for further diagnosis, but the cases identified in these investigations were often not notified to the NTP. This problem could be resolved by strengthening the referral linkages between private health providers, NTP laboratories and treatment centres through capacity building and training of their staff.

Entities:  

Keywords:  Children; Diagnosis; Management practices; Pakistan; Presumptive; Private providers; Referral; Tuberculosis

Mesh:

Year:  2021        PMID: 33413206      PMCID: PMC7791821          DOI: 10.1186/s12889-020-10053-4

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  28 in total

Review 1.  Diagnosis and treatment of tuberculosis in children.

Authors:  Delane Shingadia; Vas Novelli
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

2.  Accelerating TB notification from the private health sector in Delhi, India.

Authors:  Debashish Kundu; Kamal Chopra; Ashwani Khanna; Neeti Babbar; T J Padmini
Journal:  Indian J Tuberc       Date:  2016-04-29

3.  Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.

Authors:  M Bonnet; C Kyakwera; N Kyomugasho; D Atwine; F Mugabe; M Nansumba; Y Boum Ii; J Mwanga-Amumpaire; J Kiwanuka
Journal:  Int J Tuberc Lung Dis       Date:  2017-08-01       Impact factor: 2.373

4.  Routine EPI coverage: subdistrict inequalities and reasons for immunization failure in a rural setting in Pakistan.

Authors:  Asif Raza Khowaja; Umber Zaman; Asher Feroze; Arjum Rizvi; Anita K M Zaidi
Journal:  Asia Pac J Public Health       Date:  2011-12-20       Impact factor: 1.399

5.  Engaging the private sector to increase tuberculosis case detection: an impact evaluation study.

Authors:  Aamir J Khan; Saira Khowaja; Faisal S Khan; Fahad Qazi; Ismat Lotia; Ali Habib; Shama Mohammed; Uzma Khan; Farhana Amanullah; Hamidah Hussain; Mercedes C Becerra; Jacob Creswell; Salmaan Keshavjee
Journal:  Lancet Infect Dis       Date:  2012-06-14       Impact factor: 25.071

6.  BCG vaccination is associated with decreased severity of tuberculosis in Pakistan.

Authors:  Zahra Hasan; Muhammad Irfan; Javaid A Khan; Shehryar Khaliqdina Jahangir; Muhammad Haris; Mussarat Ashraf; Naseem Salahuddin; Bushra Jamil; Nisar A Rao
Journal:  Int J Mycobacteriol       Date:  2012-11-15

7.  Factors associated with non-utilization of child immunization in Pakistan: evidence from the Demographic and Health Survey 2006-07.

Authors:  Ayesha Siddiqa Bugvi; Rahla Rahat; Rubeena Zakar; Muhammad Zakria Zakar; Florian Fischer; Muazzam Nasrullah; Riffat Manawar
Journal:  BMC Public Health       Date:  2014-03-06       Impact factor: 3.295

8.  Factors affecting access to information on routine immunization among mothers of under 5 children in Kaduna State Nigeria, 2015.

Authors:  Lydia Taiwo; Suleiman Idris; Aisha Abubakar; Patrick Nguku; Peter Nsubuga; Saheed Gidado; Lilian Okeke; Samuel Emiasegen; Endie Waziri
Journal:  Pan Afr Med J       Date:  2017-07-10

Review 9.  Sex and gender: modifiers of health, disease, and medicine.

Authors:  Franck Mauvais-Jarvis; Noel Bairey Merz; Peter J Barnes; Roberta D Brinton; Juan-Jesus Carrero; Dawn L DeMeo; Geert J De Vries; C Neill Epperson; Ramaswamy Govindan; Sabra L Klein; Amedeo Lonardo; Pauline M Maki; Louise D McCullough; Vera Regitz-Zagrosek; Judith G Regensteiner; Joshua B Rubin; Kathryn Sandberg; Ayako Suzuki
Journal:  Lancet       Date:  2020-08-22       Impact factor: 79.321

10.  Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis.

Authors:  Emily MacLean; Giorgia Sulis; Claudia M Denkinger; James C Johnston; Madhukar Pai; Faiz Ahmad Khan
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.